
Kai Fu
Articles
-
Jan 13, 2025 |
onlinelibrary.wiley.com | Lai Wei |Jing Li |Shuai Zhang |Kai Fu
Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request
-
Jun 6, 2024 |
onlinelibrary.wiley.com | Adrian Yap |Jie Lei |Chengge Liu |Kai Fu
Corresponding Author Kai Yuan Fu Center for TMD & Orofacial Pain, Peking University School & Hospital of Stomatology, Beijing, China Department of Oral & Maxillofacial Radiology, Peking University School & Hospital of Stomatology, Beijing, China National Center for Stomatology and National Clinical Research Center for Oral Diseases, Beijing, China National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China Beijing Key Laboratory of Digital...
-
Jan 29, 2024 |
nature.com | Kai Fu
AbstractChemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms underlying chemotherapeutic agent resistance is paramount.
-
Dec 22, 2023 |
mdpi.com | Haiyan Yang |Zhe Wang |Kai Fu |Qingda Luo
1. IntroductionUrban water environment protection and resource utilization are critical for sustainable urban development.
-
Nov 6, 2023 |
mdpi.com | Kai Fu |Qianhui Wu |Ning Jiang |Sijia Hu
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →